The effect of the family-centered educational program on medication management and quality of life in elderly patients with ischemic heart disease.

The effect of the family-centered educational program on medication management and quality of life in elderly patients with ischemic heart disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180513039646N1

Enrollment

Registered

2018-09-23

Start date

2018-04-30

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease. Chronic ischemic heart disease, unspecified

Interventions

Intervention 1: Intervention group: in the intervention group, family-centered education will be provided to the patient and active member of the family in the form of three sessions of 40-30 minutes.

Eligibility

Sex/Gender

All

Age

60 Years to 75 Years

Inclusion criteria

Inclusion criteria: Reading and writing literacy (for patient or family member) Age between 60 and 75 years The absence of diagnosed psychological illness Ischemic Heart Disease Detected by Heart Disease At least 6 months have passed since the diagnosis of the disease and has a sustained pain and hemodynamic status A positive response to two or more questions is the "HbL Drug Dangers Questionnaire" that is used to assess the problems associated with drug use in the elderly. Residence of an active member of the family at or near the patient's place of residence

Exclusion criteria

Exclusion criteria: Entry into the acute phase of the disease The company participated simultaneously in other similar specialized studies Having even a session absent in the classroom for a patient or family member Unwillingness (patient and active member of the family) to continue participating in the study or death of a sick person or an active member of the family Do not answer phone at least for two times

Design outcomes

Primary

Measure	Time frame
Quality of Life: It is the individual's thoughts of his or her living conditions, according to the culture and value system in which they live, and the relation of these receipts to their goals, expectations, expectations, standards and priorities. Pharmaceutical Management: Includes patient-focused care that optimizes safe, effective, and effective drug treatment, and is provided through collaboration with patients and their care team. Timepoint: These variables are measured at the beginning of the study and three months after the intervention. Method of measurement: The quality of life in this study is a score that a person earns based on the LEIPAD Quality of Life Questionnaire.	—

Measure

Time frame

Quality of Life: It is the individual's thoughts of his or her living conditions, according to the culture and value system in which they live, and the relation of these receipts to their goals, expectations, expectations, standards and priorities. Pharmaceutical Management: Includes patient-focused care that optimizes safe, effective, and effective drug treatment, and is provided through collaboration with patients and their care team. Timepoint: These variables are measured at the beginning of the study and three months after the intervention. Method of measurement: The quality of life in this study is a score that a person earns based on the LEIPAD Quality of Life Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Sadat Hejazi

Tehran University of Medical Sciences

zahra.s.hejazi@hotmail.com+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026